Document is current

Article History

Received: 20 April 2022

Accepted: 29 September 2022

First Online: 10 October 2022

Declarations

:

: This article does not contain any studies with human participants or animals performed by any of the authors.

: Not applicable.

: This manuscript is original research that has not been previously published or submitted for publication elsewhere while under consideration. Doris K. Hansen reports financial relationships within the past 12 months from OncLive (honoraria). Hamza Hashmi is on the advisory board for Janssen, Sanofi, and Bristol Myers Squibb. The rest of the authors declare no conflict of interest with this manuscript and have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants, or patents received or pending, or royalties.